share on google plus
Text size
view with small font size
view with medium font size
view with large font size


LEUNASE® contains L-Asparaginase obtained from E. coli HAP modified strain. It has a superior effect in inducing remission, especially for acute lymphoblastic leukemia, and no cross resistance with other drugs.

Marketed by Kyowa Hakko Kirin in

Japan, Korea, Singapore, Taiwan, South Africa, Thailand

Worldwide Locations

To Page Top